New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ABT;FII;ABBV From The Last 14 Days
Check below for free stories on ABT;FII;ABBV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
15:16 EDTABBVDEA restricts painkiller drug prescriptions to curb abuse, WSJ reports
The Drug Enforcement Agency, or DEA, will reclassify hydrocodone combination painkiller drugs and place them in the category of medical substances that have the highest potential for harm in an attempt to curb the widespread abuse of the drugs, according to The Wall Street Journal. The rescheduling of the drugs will take effect in 45 days and result in people being able to obtain the drug for only 90 days without obtaining a new prescription. Major manufacturers of these drugs include Teva Pharmaceutical (TEVA), Mallinckrodt (MNK), AbbVie (ABBV), and Actavis (ACT). Reference Link
10:14 EDTFIIOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AllianceBernstein (AB) initiated with a Hold at Jefferies... Federated Investors (FII) initiated with a Buy at Jefferies... Heritage-Crystal Clean (HCCI) initiated with a Hold at Stifel... MDC Partners (MDCA) initiated with an Outperform at FBR Capital... MeetMe (MEET) initiated with an Outperform at JMP Securities... PNM Resources (PNM) initiated with a Hold at KeyBanc... Perficient (PRFT) initiated with a Buy at Maxim... Summit Hotel Properties (INN) initiated with an Outperform at JMP Securities... Tesla (TSLA) initiated with an Outperform at CLSA... Tyler Technologies (TYL) initiated with a Buy at Maxim... US Ecology (ECOL) initiated with a Buy at Stifel... Vertex Energy (VTNR) initiated with a Buy at Stifel.
07:57 EDTABBVGilead HCV risks overblown, says Bernstein
Bernstein believes that investors are concerned about upcoming competition to Gilead's (GILD) HCV drug from AbbVie's (ABBV) HCV treatment. But Bernstein says that insurers can only prevent 16% of the U.S. population from receiving Gilead's drug, and the firm does not expect the HCV market share dynamics to change in the near-term. It keeps an Outperform rating on Gilead.
05:20 EDTFIIFederated Investors initiated with a Buy at Jefferies
Subscribe for More Information
August 18, 2014
09:00 EDTABTAbbott and Defense Department to develop portable blood tests
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use